Open AccessEarly Diagnosis of HIV in Children below 18 months using DNA PCR Test--Assessment of the Effectiveness of PMTCT Interventions and Challenges in Early Initiation of ART in a Resource-Limited Setting
Author(s) -
Ajay Gupta,
Girraj Pratap Singh,
Pratap Bhan Kaushik,
B. C. Joshi,
Kamlesh Kalra,
Sabyasachi Chakraborty
Publication year - 2012
Publication title -
journal of tropical pediatrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.464
H-Index - 51
eISSN - 1465-3664
pISSN - 0142-6338
DOI - 10.1093/tropej/fms063
Subject(s) - nevirapine , medicine , regimen , dried blood spot , pediatrics , psychological intervention , transmission (telecommunications) , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy , immunology , genetics , biology , electrical engineering , engineering , psychiatry
This study was conducted to assess efficacy of the current Indian Prevention of Mother-to-Child Transmission (PMTCT) protocol in 217 HIV-exposed infants, and to assess challenges in the early initiation of antiretroviral treatment (ART) in 18 (8.3%) infants with HIV, as determined by the HIV-1 DNA polymerase chain reaction (PCR) test at ≥ 6 weeks to <18 months of age. The mother-to-child transmission (MTCT) rate in 154 mother-baby pairs fully compliant with the PMTCT protocol was 5.2%. However, if 25 pairs who were positive using dried blood spot (DBS) DNA PCR and who did not undergo whole blood testing are included in the analysis, then the overall MTCT rate would be 19.8%. The current protocol is 50% effective considering an MTCT rate of 35-40% without any intervention. ART was initiated in 10 (55.6%) HIV-infected children at a mean ± standard deviation (SD) age of 10.45 ± 4.9 (range: 4-17.5) months; delay resulted in opportunistic infections in one-third of the children. A single-dose nevirapine PMTCT regimen should be replaced by a triple antiretroviral regimen; DBS DNA PCR-positive infants may be given ART, and simultaneously a whole blood specimen should be taken to determine whether ART should be continued.